SciELO - Scientific Electronic Library Online

 
vol.116 número3Pseudotumor cerebral asociado a hipovitaminosis A, B6 y D: A propósito de dos casosBlastoma pleuropulmonar: reporte de un caso índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Archivos argentinos de pediatría

versión impresa ISSN 0325-0075versión On-line ISSN 1668-3501

Resumen

ROSANOVA, María T et al. Use of posaconazole in children: Experience in a tertiary pediatric hospital. Arch. argent. pediatr. [online]. 2018, vol.116, n.3, pp.e451-e454. ISSN 0325-0075.  http://dx.doi.org/10.5546/aap.2018.e451.

There is limited information on the use of posaconazole in children. This retrospective and descriptive study was conducted to evaluate the clinical, microbiological characteristics and evolution of patients treated with posaconazole between August 2010 and March 2017. We included 16 children. Median age: 161 months (interquartile range -IQR-69-173m). All had underlying disease and a proven invasive fungal infection. The most frequent isolated were Mucor spp. and Aspergillus spp. The mean posaconazole dose was 600 mg /day (400-800 mg/day) and the median duration of treatment was 223 days (IQR 48-632). Ten patients had adverse effects, but only one required suspension of the antifungal treatment due to hydroelectrolytic disorders.

Palabras clave : Posaconazole; Treatment; Invasivefungal infections; Child.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons